Dr. Olivier Clément, PhD, and Dr. Pierre-Henri Lefevre[email protected]Clinical NewsGadolinium chelates for MRI: Where are we now?The safety of MRI contrast agents came under close scrutiny at the Journées Francophones de Radiologie congress. Dr. Olivier Clément, PhD, from Paris and Dr. Pierre-Henri Lefevre from Nîmes provided timely summaries of the current and future status of these products and asked what the literature tells us.October 17, 2016Page 1 of 1Top StoriesECR 2026Video from ECR: MRI safety expert highlights role of national guidance in EuropeMRI safety was not always on the agenda. At ECR 2026, safety expert Titti Owman reflects on four decades in the field and why clear national guidance could strengthen MRI training and safety practices across Europe.Womens ImagingThe future of BI-RADS includes AIAIPerspective: Reporting transparency is essential in AI studiesMRIUnstable brain networks may drive multiple sclerosis fatigueWomens ImagingAI-calculated BAC on mammograms predicts cardiovascular disease in women
